Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corteva (CTVA) Cash & Equivalents (2018 - 2025)

Corteva has reported Cash & Equivalents over the past 8 years, most recently at $4.5 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 45.56% year-over-year to $4.5 billion; the TTM value through Dec 2025 reached $4.5 billion, up 45.56%, while the annual FY2025 figure was $4.5 billion, 45.56% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $4.5 billion at Corteva, up from $2.5 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $4.5 billion in Q4 2025 and troughed at $1.5 billion in Q1 2024.
  • A 5-year average of $2.6 billion and a median of $2.4 billion in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: decreased 28.44% in 2022 and later surged 45.56% in 2025.
  • Year by year, Cash & Equivalents stood at $4.5 billion in 2021, then decreased by 28.44% to $3.2 billion in 2022, then dropped by 17.14% to $2.6 billion in 2023, then grew by 17.47% to $3.1 billion in 2024, then skyrocketed by 45.56% to $4.5 billion in 2025.
  • Business Quant data shows Cash & Equivalents for CTVA at $4.5 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.1 billion in Q2 2025.